Stroke: Fresh insights into causes, prevention, and treatment

The Lancet Neurology

Volumn 10, Issue 1, 2011, Pages 2-3

  Hankey, Graeme J ^a,b  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CILOSTAZOL; CLOPIDOGREL; DIPYRIDAMOLE;

BLOOD PRESSURE; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CLINICAL TRIAL; FIBRINOLYSIS; HUMAN; LIFESTYLE; MEDICAL INFORMATION; NOTE; PREVALENCE; PRIORITY JOURNAL; REPERFUSION INJURY; REVASCULARIZATION; STROKE; SYSTOLIC BLOOD PRESSURE; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERNATIONAL COOPERATION; MALE; META-ANALYSIS AS TOPIC; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; STROKE;

EID: 78650005419     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(10)70279-9     Document Type: Note

References (9)

1. O'Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010, 376:112-123. on behalf of the INTERSTROKE investigators.
2. Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010, 375:895-905.
3. Webb AJS, Fisher U, Mehta Z, Rothwell PM Effects of antihypertensive drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet 2010, 375:906-915.
4. Lees KR, Bluhmki E, von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010, 375:1695-1703. for the ECASS, ATLANTISATLANTIS, NINDSNINDS, EPITHET rt-PA Study Group InvestigatorsEPITHET rt-PA Study Group Investigators.
5. Shinohara Y, Katayama Y, Uchiyama S, et al. Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial. Lancet Neurol 2010, 9:959-968. for the CSPS 2 group.
6. Short-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis: a preplanned meta-analysis of individual patient data. Lancet 2010, 376:1062-1073. Carotid Stenting Trialists' Collaboration.
7. Brott TG, Hobson RW, Howard G, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 2010, 363:11-23. for the CREST investigators.
8. Ederle J, Dobson J, Featherstone RL, et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial. Lancet 2010, 375:985-997. International Carotid Stenting Study investigators.
9. Rothwell PM Poor outcomes after endovascular treatment of symptomatic carotid stenosis: time for a moratorium. Lancet Neurol 2009, 8:871-873.